Latin America hosts some of the most progressive health-related marijuana deregulations in the planet. A total of eight nations have legalized some type of health-related marijuana use across Central and South America.

Every single country’s legislation permits distinct levels of cultivation, distribution, and manufacturing, which can represent important monetary gains for investors and the nations themselves.

Right here is PotNetwork’s overview of how deregulation is affecting distribution in Mexico, Colombia, Uruguay, Panama, Argentina, Chile, Peru, and Brazil.

PotNetwork News Speaks With Former Mexican President Vicente Fox from Potnetwork on Vimeo.


Cannabis has been de-regulated in Mexico considering that 2009, but there continues to be no path for legal cultivation. As an alternative, the nation imports cannabis solutions and supplies licenses to firms for pharmacy distribution.

HempMeds Mexico, a subsidiary of Healthcare Marijuana Inc. (OTCMKTS:MJNA) and Green Lotus, a private business primarily based in Colorado, are amongst the businesses licensed to provide CBD solutions to pharmacies. Seven pharmaceutical businesses, 4 primarily based in Mexico, received licenses to distribute 38 CBD solutions in the initial licensing course of action in late 2018.

[Former President of Mexico Vicente Fox On Cannabis: “We Must Move Ahead With Legalization”]

The Mexican government is at the moment evaluating a bill that would legalize recreational and health-related marijuana use in the nation.


Colombia is historically 1 of the most infamous names in the cannabis market place, even though not due to its deregulation. The nation decriminalized tiny amounts of cannabis in 2009 and in 2016 deregulated cultivation.

Additional than any other nation, Colombia seeks notoriety for its internal and external distribution and has currently supplied a license to Khiron to construct a major grade health-related processing facility.

In February, Clever Leaves became the very first Colombian cannabis business to get an import license in Canada. Clever Leaves, Khiron Life Sciences Corp (OTCQB:KHRNF) (TSXV:KHRN), and Blueberries Healthcare Corp. (CSE:BBM), a Colombian cannabis-primarily based solutions business, are amongst these who received licenses and plots for cultivation.


Uruguay maintains the title of the very first nation in Latin America to decriminalize cannabis.

Its dwelling-cultivation laws are some of the most deregulated in Latin America, but they face distribution and importation hangups for health-related sufferers.

[Uruguay’s attempts to enter the global cannabis market fall flat as marijuana shortages abound]

Fourteen pharmacies are authorized to sell health-related cannabis solutions but are frequently understocked. A total of 7 businesses are licensed to develop health-related cannabis, five of these licenses are brand new.


Panama introduced a medicinal marijuana bill in March 2016. Now, in 2019, the bill is heading to the labor and overall health committees of the country’s national assembly exactly where regulations will be debated and constructed.

At the moment, there are no distribution regulations in Panama with regards to health-related cannabis.


Argentina has an import-only market place for health-related use.

In February 2019, they announced a partnership with Nevada primarily based, Player’s Network, Inc. (OTCQB:PNTV). Player’s Network received permission to cultivate for analysis, not health-related use.

This week, Aphria (NYSE:APHA), a Canadian-primarily based cannabis producer and distributor, received an exclusive import and provide agreement from the government to import straight to pharmacies. This deal provides Aphria a monopoly on the Argentinian market place.


Chile is at the forefront of distribution and importing and exporting. Their health-related marijuana deregulation bill, which passed in 2015, permits in-nation cultivation and manufacturing.

Tilray, Inc. (NASDAQ:TLRY), and it is subsidiary Alef Biotechnology, SpA, distribute Salcobrand solutions to pharmacies and will be developing a manufacturing facility.

Khiron also received permission to start production and, most likely, manufacturing in Chile.


Just final week, Peru announced deregulation recommendations, with statutes for distribution and sale.

At the moment, Plena Worldwide Holdings Inc., a private Canadian firm, is the dominant player in Peru, assisting construct the legislation and getting an exclusive distribution agreement for medicinal CBD oil.

[Peru announces marijuana deregulation guidelines 15 months after legalizing medical marijuana]

Khiron, also, is supplying CBD cosmetics to the Peruvian market place below their brand, Kuida. It is accessible by means of on line and retail channels.


Brazil is at a health-related marijuana crossroads. Their government gradually deregulated all through the early aughts, like legalizing medicinal CBD in 2015.

The country’s new president, who assumed energy in early 2019, is not a proponent of CBD.  The country’s market place forces seem to be moving forward with, or without having, his approval.

As it stands, the market place is restricted. There is no health-related marijuana cultivation permitted, but in early 2017, Elixinol Worldwide (ASX:EXL) (OTC:ELLXF), received provide and distribution permission. Additional not too long ago, HempMeds, a Californian CBD oil producer, opened HempMeds Brazil in late 2018.